wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q38930362-186A63A8-ACE2-496D-97DE-0C6D2F2DC5E6
Q38930362-186A63A8-ACE2-496D-97DE-0C6D2F2DC5E6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38930362-186A63A8-ACE2-496D-97DE-0C6D2F2DC5E6
Targeted Therapies for Lung Cancer.
P2860
Q38930362-186A63A8-ACE2-496D-97DE-0C6D2F2DC5E6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38930362-186A63A8-ACE2-496D-97DE-0C6D2F2DC5E6
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
f1835d725a4202497bec0d17213c4ebef0d0312b
P2860
Health-related quality-of-life in a randomized phase III first-line study of gefitinib versus carboplatin/paclitaxel in clinically selected patients from Asia with advanced NSCLC (IPASS).